Medicare Enrolled
Dr. Gurmit Gill, MD
Pulmonary Disease · Garden City, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gill from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gill?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gill
Dr. Gurmit Gill is a pulmonary disease specialist in Garden City, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gill performed 19,753 Medicare services across 2,559 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gill received a total of $143,726 from 68 pharmaceutical and/or device companies across 1728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gill is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in NY
$143,726 industry payments
Medicare Practice Summary
Medicare Utilization ↗19,753
Medicare services
Top 1% in NY for pulmonary disease
2,559
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~988 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy immunotherapy preparation A professional service involving the preparation and administration of one or more antigens. |
5,820 | $15 | $30 |
| Allergy skin test A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens. |
3,312 | $4 | $15 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,947 | $0 | $100 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
1,245 | $37 | $300 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,231 | $113 | $600 |
| Skin allergy test A test where small amounts of potential allergens are injected into the skin to check for allergic reactions. |
1,140 | $8 | $15 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
871 | $13 | $200 |
| Allergy injection therapy, multiple injections A professional service involving the administration of multiple allergen injections. |
746 | $12 | $200 |
| Electrocardiogram, 1-3 leads with physician review A heart rhythm test using one to three electrodes to record electrical activity, with interpretation by a physician. |
322 | $12 | $200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
315 | $162 | $700 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
276 | $199 | $858 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
227 | $110 | $600 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
190 | $70 | $155 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
153 | $1 | $100 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
150 | $65 | $500 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
119 | $31 | $150 |
| Exhaled air test for lung function A test that measures exhaled air to evaluate lung function while at rest and during exercise. |
114 | $51 | $150 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
110 | $42 | $150 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
109 | $55 | $200 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
59 | $614 | $1,225 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
55 | $17 | $100 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
54 | $160 | $600 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
42 | $585 | $1,225 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
39 | $26 | $200 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
34 | $153 | $700 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $31 | $400 |
| Eardrum and muscle function test A diagnostic test used to evaluate the function of the eardrum and associated muscles. |
13 | $20 | $300 |
| New patient office visit, complex (60-74 min) | 12 | $207 | $800 |
| Insertion of non-tunneled central venous catheter A procedure to place a central venous catheter for infusion in patients aged 5 years or older. The catheter is inserted directly into a large vein without being tunneled under the skin. |
11 | $78 | $1,540 |
| Health risk assessment administration and interpretation This procedure involves administering a health risk assessment to a patient and interpreting the results. |
11 | $3 | $50 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
25.4% medium
74.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$143,726
Total received (2018-2024)
Avg $20,532/year across 7 years
Top 4% in NY for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
1,728
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$105,232 (73.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,136 (23.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,357 (3.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,017
2023
$18,542
2022
$26,075
2021
$13,613
2020
$13,349
2019
$50,870
2018
$17,261
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
HARMONY BIOSCIENCES LLC
$807
AstraZeneca Pharmaceuticals LP
$410
JAZZ PHARMACEUTICALS INC.
$401
Regeneron Healthcare Solutions, Inc.
$395
GlaxoSmithKline, LLC.
$281
GENZYME CORPORATION
$260
Mallinckrodt Hospital Products Inc.
$176
ANI Pharmaceuticals, Inc.
$149
Takeda Pharmaceuticals U.S.A., Inc.
$133
Grifols USA, LLC
$121
Paratek Pharmaceuticals, Inc.
$92
Genentech USA, Inc.
$85
Amgen Inc.
$83
ABBVIE INC.
$83
Baxter Healthcare
$70
Philips North America LLC
$59
Electromed, Inc.
$57
Mylan Specialty L.P.
$53
ALK-Abello, Inc
$44
Hikma Pharmaceuticals USA
$42
Novartis Pharmaceuticals Corporation
$32
Lundbeck LLC
$27
Janssen Pharmaceuticals, Inc
$25
Novo Nordisk Inc
$24
Intra-Sana Laboratories
$24
IDORSIA PHARMACEUTICALS US INC
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
PFIZER INC.
$22
3B Medical, Inc.
$17
Top 3 companies account for 40.3% of 2024 payments
All-time payments by company (2018-2024) ›
Mallinckrodt Hospital Products Inc.
$44,704
Mallinckrodt Enterprises LLC
$32,442
Sunovion Pharmaceuticals Inc.
$13,339
Mylan Specialty L.P.
$12,505
Mallinckrodt LLC
$6,676
AstraZeneca Pharmaceuticals LP
$5,243
GlaxoSmithKline, LLC.
$4,367
Regeneron Healthcare Solutions, Inc.
$2,596
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,314
Harmony Biosciences LLC
$2,010
Grifols USA, LLC
$1,426
Genentech USA, Inc.
$1,279
GENZYME CORPORATION
$1,257
HARMONY BIOSCIENCES LLC
$1,112
JAZZ PHARMACEUTICALS INC.
$1,041
Philips Electronics North America Corporation
$894
ARBOR PHARMACEUTICALS, INC.
$658
Takeda Pharmaceuticals U.S.A., Inc.
$645
ALK-Abello, Inc
$568
Jazz Pharmaceuticals Inc.
$543
Amgen Inc.
$529
Novartis Pharmaceuticals Corporation
$459
OptiNose US, Inc.
$448
Shire North American Group Inc
$401
Baxter Healthcare
$400
Axsome Therapeutics, Inc.
$352
ANI Pharmaceuticals, Inc.
$311
Electromed, Inc.
$308
Horizon Therapeutics plc
$296
Merck Sharp & Dohme Corporation
$286
Advanced Respiratory, Inc
$274
Merck Sharp & Dohme LLC
$241
Insmed, Inc.
$233
Teva Pharmaceuticals USA, Inc.
$231
PFIZER INC.
$228
SANOFI-AVENTIS U.S. LLC
$221
Medical Graphics Corporation
$200
IDORSIA PHARMACEUTICALS US INC
$199
Novo Nordisk Inc
$187
Circassia Pharmaceuticals Inc
$168
Eisai Inc.
$163
Gilead Sciences, Inc.
$156
Optinose US, Inc.
$152
Nabriva Therapeutics, plc
$148
Hikma Pharmaceuticals USA
$146
Resmed Corp
$143
Exeltis, USA Inc.
$133
ADVANCED RESPIRATORY, INC
$125
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$103
Arbor Pharmaceuticals, Inc.
$95
CSL Behring
$92
Paratek Pharmaceuticals, Inc.
$92
Actelion Pharmaceuticals US, Inc.
$84
ABBVIE INC.
$83
Pharming Healthcare, Inc.
$69
Philips North America LLC
$59
Janssen Pharmaceuticals, Inc
$42
Inogen, Inc.
$33
Currax Pharmaceuticals LLC
$29
Lundbeck LLC
$27
EISAI INC.
$25
Intra-Sana Laboratories
$24
LEO Pharma Inc.
$24
Inspire Medical Systems, Inc.
$20
Supernus Pharmaceuticals, Inc.
$19
Eyevance Pharmaceuticals LLC
$18
3B Medical, Inc.
$17
Phadia US Inc.
$15
Top 3 companies account for 63.0% of all-time payments
Associated products mentioned in payments ›
(2547) Sleep Other · (2922) Trilogy O2 · (7999) SRC Undivided · (8359) DreamWear Pillows · (8874) inCourage · (8944) Trilogy Evo Univ · (AK6) Vest Therapy · ACTHAR · ADBRY · AIR 11 · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · ASMANEX · AUSTEDO · AirDuo Digihaler · Arikayce · Astral · BELSOMRA · BEVESPI AEROSPHERE · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BROVANA · Bidil · CHANTIX · CINQAIR · CINRYZE · CONTRAVE · CUTAQUIG · CUVITRU · CYCLOSET · DUAKLIR PRESSAIR · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · DreamStat Cpap Auto · DreamWear · DreamWear Pillows · Dymista · ELIQUIS · Edarbi · Edarbyclor · Esbriet · Evekeo · Evekeo ODT · FARXIGA · FASENRA · GLASSIA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - VisiVest Airway Clearance System · Hizentra · Horizant · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ImmunoCAP · InogenOne · JARDIANCE · LONHALA MAGNAIR · LUNA · NUCALA · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · Odactra · Ozempic · PAXLOVID · PENNSAID · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · QELBREE · QUVIVIQ · RAYOS · RELTONE 200 MG · REXULTI · RUCONEST · Ragwitek · Respiratoriy Care Undiv · Ryaltris · Rybelsus · SEEBRI · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · SRC Und · STIOLTO · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sleep Other · Sunosi · TAKHZYRO · TEZSPIRE · TOUJEO · TRELEGY ELLIPTA · TUDORZA PRESSAIR · The Vest System Model 105 Home Care · The VisiVest Airway Clearance System · Tobradex ST · Trilogy 100 · UPTRAVI · UTIBRON · UTIBRON NEOHALER · VRAYLAR · WAKIX · Wakix · Wegovy · Wellcentive Undiv · XARELTO · XIFAXAN · XOLAIR · XYREM · XYWAV · Xembify · Xenleta · Xhance · Xofluza · Xolair · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (73%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for pulmonary disease in NY.
Geographic Context
Pulmonary diseases within 10 mi
573
Per 100K population
41.3
County median income
$143,408
Nearest hospital
LONG ISLAND JEWISH MEDICAL CENTER
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gill is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with speaking/promotional industry engagement in the top 4% of NY peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gill experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Gill performed 5,820 allergy immunotherapy preparation services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gill receive payments from pharmaceutical companies?
Yes. Dr. Gill received a total of $143,726 from 68 companies across 1,728 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gill's costs compare to other pulmonary diseases in Garden City?
Dr. Gill's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gill) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Garden City
Browse pulmonary diseases in Garden City ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in NY
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in NY
Which NY pulmonary diseases receive the most from drug and device companies.
By company
Mallinckrodt Hospital Products Inc. Payments to Doctors
See all physicians who received payments from Mallinckrodt Hospital Products Inc.
By company
Mallinckrodt Enterprises LLC Payments to Doctors
See all physicians who received payments from Mallinckrodt Enterprises LLC.
By company
Sunovion Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Sunovion Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology